Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer

Accumulating evidence suggests that metformin, a biguanide class of anti-diabetic drugs, possesses anti-cancer properties. However, most of the studies to evaluate therapeutic efficacy of metformin have been on primary cancer. No information is available whether metformin could be effectively used f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nangia-Makker, Pratima, Yu, Yingjie, Vasudevan, Anita, Farhana, Lulu, Rajendra, Sindhu G., Levi, Edi, Majumdar, Adhip P. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896365/
https://www.ncbi.nlm.nih.gov/pubmed/24465408
http://dx.doi.org/10.1371/journal.pone.0084369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896365/
https://www.ncbi.nlm.nih.gov/pubmed/24465408
http://dx.doi.org/10.1371/journal.pone.0084369

Ejemplares similares